Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-19

Clinical Trial Update: L-Arginine Supplements in Treating Women Who Are Cancer Survivors [NA]

View source ↗

Summary

Clinical trial evaluating L-Arginine supplements for sexual dysfunction in women cancer survivors; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-Arginine (L-Arginine)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Sexual Dysfunction, Sexuality and Reproductive Issues | NA | Status: COMPLETED | Results posted: 2015-01-19